Digestive & Intestinal Remedies (Pharmacies) - Ireland

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$17.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.06%, resulting in a market volume of US$17.45m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$3.44 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Ireland is experiencing significant growth and development.

Customer preferences: Customers in Ireland are increasingly seeking digestive and intestinal remedies from pharmacies. This can be attributed to several factors, including the growing awareness about digestive health and the importance of maintaining a healthy gut. Additionally, the convenience of purchasing these remedies from pharmacies, which are easily accessible and often provide expert advice, is also driving customer preferences.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies market in Ireland is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients in the products they consume and are opting for natural alternatives. This trend is in line with the global shift towards natural and organic products. Pharmacies in Ireland are responding to this trend by expanding their range of natural digestive and intestinal remedies. Another trend in the market is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help in maintaining a healthy balance of gut bacteria and can alleviate digestive issues. The demand for probiotics is driven by the growing awareness about their benefits and their effectiveness in improving gut health. Pharmacies in Ireland are stocking a wide range of probiotic products to cater to this demand.

Local special circumstances: Ireland has a high prevalence of digestive disorders, such as irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). These conditions contribute to the demand for digestive and intestinal remedies. The Irish population's diet, which is often high in processed foods and low in fiber, can also lead to digestive issues. As a result, there is a higher demand for remedies that can alleviate these symptoms and improve digestive health.

Underlying macroeconomic factors: The growing economy in Ireland is positively impacting the Digestive & Intestinal Remedies market. As disposable incomes increase, consumers have more purchasing power and are willing to spend on healthcare products. This has led to a higher demand for digestive and intestinal remedies, as consumers prioritize their health and well-being. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Ireland is witnessing growth and development due to customer preferences for convenient access to remedies, increasing demand for natural and herbal products, and the rising popularity of probiotics. The local special circumstances, such as the high prevalence of digestive disorders and the Irish diet, further contribute to the market's growth. The underlying macroeconomic factors, including the growing economy and higher disposable incomes, also play a significant role in driving the market forward.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.